Updated Jul 16, 2026
JIMENEZ JOSEPH has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $4.00M.

Joseph Jimenez is a prominent business executive best known for serving as CEO of Novartis AG from 2010 to 2018. In the SEC filing context provided, he is listed as a Director for Procter & Gamble Co and for Century Therapeutics, Inc. as of March 11, 2026, indicating continued involvement in corporate governance across both consumer goods and biotechnology. His career spans executive leadership roles in global pharmaceutical and healthcare industries, with board experience at multinational corporations.
| Role | Director |
|---|---|
| Notability | 85/100 |
| Links | Wikipedia |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | PG | PROCTER GAMBLE Co | A — Grant or award | 320 | $0.00 | |
| 2026-06-08 | QNT | Quantinuum Inc. | P — Open-market purchase | 66.7K | $60.00 | $4.00M |
| 2026-06-08 | QNT | Quantinuum Inc. | A — Grant or award | 5.8K | $0.00 | |
| 2026-03-11 | PG | PROCTER GAMBLE Co | A — Grant or award | 273 | $0.00 | |
| 2025-10-14 | PG | PROCTER GAMBLE Co | A — Grant or award | 1.5K | $0.00 | |
| 2025-09-09 | PG | PROCTER GAMBLE Co | A — Grant or award | 298 | $0.00 | |
| 2025-06-10 | PG | PROCTER GAMBLE Co | A — Grant or award | 292 | $0.00 | |
| 2024-12-11 | PG | PROCTER GAMBLE Co | A — Grant or award | 276 | $0.00 | |
| 2024-10-09 | PG | PROCTER GAMBLE Co | A — Grant or award | 1.3K | $0.00 |
Joseph Jimenez is a prominent business executive best known for serving as CEO of Novartis AG from 2010 to 2018. In the SEC filing context provided, he is listed as a Director for Procter & Gamble Co and for Century Therapeutics, Inc. as of March 11, 2026, indicating continued involvement in corporate governance across both consumer goods and biotechnology. His career spans exe…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($4.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live JIMENEZ JOSEPH profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.